This content is in French.
IL-41 in resistance to Kawasaki disease treatments
29 mars 2024
In this study, researchers examined the importance of IL-41 in clinical parameters and treatment resistance in Kawasaki disease. A total of 93 children with the disease were included. Serum IL-41…
Sign in to read the rest
Reserved for healthcare professionals, free registration.
Scientific reference
Yan Duan et al. Serum IL-41 might be a biomarker for IVIG resistance and coronary artery lesions in Kawasaki disease. Int Immunopharmacol. 2023 Sep:122:110600.
View the source
